EarningsQ2 2025 Earnings Report

Nektar Therapeutics (NKTR) Q2 2025 Earnings Report

0 Followers

MX:NKTR Q2 2025 EPS Results

Actual EPS-$53.57

Consensus EPS-$54.99

Beat/MissBeat by +$1.42

One Year Ago EPS-$68.10

Actual Revenue$202.95M

Expected Revenue$172.33M

Beat/MissBeat by +$30.62M

YoY Revenue Growth-52.42%

QuarterQ2 2025

Date08/07/2025

TimeAfter Close

Conference CallThursday, August 7, 2025

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q2 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-38.12 / -	-33.96	―
Aug 13, 2026	2026 (Q2)	-35.79 / -22.34	-53.574	58.31% (+31.24)
May 07, 2026	2026 (Q1)	-28.73 / -33.05	-65.378	49.44% (+32.33)
Mar 12, 2026	2025 (Q4)	-44.93 / -32.33	8.172	-495.56% (-40.50)
Nov 06, 2025	2025 (Q3)	-48.76 / -33.96	-49.034	30.74% (+15.07)
Aug 07, 2025	2025 (Q2)	-54.99 / -53.57	-68.103	21.33% (+14.53)
May 08, 2025	2025 (Q1)	-46.56 / -65.38	-51.758	-26.32% (-13.62)
Mar 12, 2025	2024 (Q4)	-36.94 / 8.17	-59.93	113.64% (+68.10)
Nov 07, 2024	2024 (Q3)	-54.21 / -49.03	-65.378	25.00% (+16.34)
Aug 08, 2024	2024 (Q2)	-50.40 / -68.10	-73.551	7.41% (+5.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed